Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06078137 · ClinicalTrials.gov registry record · NA

Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates

A NA study of PROM, sponsored by University of Texas at Austin.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06078137: Active NA study of PROM, sponsored by University of Texas at Austin.

NCT06078137 is a NA study of PROM that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06078137, a NA study of PROM, is active but no longer recruiting, sponsored by University of Texas at Austin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

in clinical practice has been curbed by issues related to the variability in use of these tools for decision-making, and universally poor completion rates over time. Patients may not see the relevance of responding to questions about their health, and the results may not be reviewed by the clinician or presented and visualized with the patient. The questions may seem impersonal (e.g. too general and not directly assessing their individual goals, motivations, aspirations), irrelevant (e.g., asking about symptoms of depression when a person is seeking musculoskeletal specialty care) and insensitive (e.g., asking about sensitive subjects at the outset thereby disengaging the individual), and redundant or awkward (e.g., presenting questions that seem very similar or administered in strange orders). Finally, PROMs may also confer some burden (e.g., long PROM questionnaires often used for research may be unnecessarily burdensome for patient care), and provide logistical challenges (e.g., difficulties in administering the tools at the right time points), adding to a poor patient experience.

Primary Outcome

We will assess the completion of 3-survey patient-reported outcome measure at 6-week follow-up via Text.

Conditions Studied

Interventions

  • OTHER Usual PROMs and new PROMs strategy

Study Locations (1)

Texas

  • University of Texas Health Austin - Austin

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-09-01
Est. Completion 2025-12-01
Phase NA
University of Texas at Austin

257 total trials

What the registry record for NCT06078137 still lists

NCT06078137 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 1 condition, with PROM appearing as the primary indexed condition, and to 1 intervention - of which Usual PROMs and new PROMs strategy is the first listed.

NCT06078137 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06078137 about?

NCT06078137 is a clinical study titled "Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates". in clinical practice has been curbed by issues related to the variability in use of these tools for decision-making, and universally poor completion rates over time. Patients may not see the relevance of responding to questions about their health, and the results may not be reviewed by the clinician...

What is the current status of trial NCT06078137?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-09-01. Estimated completion is 2025-12-01.

What conditions does trial NCT06078137 study?

This clinical trial studies the following conditions: PROM.

What interventions are being tested in trial NCT06078137?

The interventions under investigation include: Usual PROMs and new PROMs strategy (OTHER).

Who is sponsoring clinical trial NCT06078137?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06078137 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PROM

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06078137's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06078137, the US trial registry maintained by the National Library of Medicine. NCT06078137 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.